General Atlantic Portfolio
Our portfolio companies are already on a strong growth trajectory — our goal is to enhance it. We have a solid track record of delivering strategic, practical and impactful support to our portfolio companies.
Chi-Med ×
Hutchison China MediTech is an integrated biopharmaceutical company in China focused on innovative oncology therapies.